European Archives - Page 46 of 1108 - European Medical Journal

Machine Learning in Liver Fibrosis Diagnosis and Progression

Recent developments in machine learning have allowed researchers to reconstruct long-term disease patterns.

DeepHealth’s Naiara Martínez Cabrera on AI's role in radiology

In this episode, uncover how AI is shaking up the radiology space with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth.

Diabetes Doubles Mortality Risk in Patients Undergoing Bifurcation PCI

Diabetes raises heart stent risks, but imaging guidance closes outcome gap. Study urges protocol changes.

Research Identifies New Inflammatory Markers as Predictors of Osteoporosis

A recent study highlights the role of inflammation in osteoporosis, identifying AISI, SIRI, and SII as key inflammatory markers associated with lower bone mineral density (BMD) in older adults.

Early Intervention for Children with Autism in Low-Resource District

A recent clinical project aimed at addressing healthcare gaps for young children in an immigrant, low-resource district has shown promising results in early identification and intervention for autism and other neurodevelopmental issues.

Lack of Transportation Lowers Breast Cancer Screening Adherence by 41%

New research highlights how transportation insecurity plays a critical role in breast cancer screening adherence, with individuals facing transportation challenges being 41% less likely to undergo mammograms.

Measles Cases Surge in Europe, Vaccination Urged

Measles cases in the EU/EEA have risen dramatically over the past year, with numbers far exceeding those reported in 2023.

Breakthrough Nanosensor Test Identifies Pancreatic Cancer Earlier

A new blood test, PAC-MANN-1, could dramatically improve early detection of pancreatic cancer, one of the deadliest malignancies.

Melanoma Disparities in Veterans: Understanding the Impact

A national cohort study found that veterans in the most disadvantaged areas had a higher risk of being diagnosed with thicker melanomas.

AstraZeneca buys EsoBiotec in $1bn cell therapy deal

AstraZeneca has announced a $1bn agreement to acquire EsoBiotec, a Belgian biotech firm pioneering in vivo cell therapies.